10 Allscripts Healthcare Solutions Analyst Ratings, Earnings, Dividends and Insider Trades | $MDRX | NASDAQ:MDRX | Analyst Ratings Network Follow @RatingsNetwork Find a Company: Login Stock Ratings Today's Ratings U.S. Analyst Ratings (NYSE and NASDAQ) All U.S. Ratings Upgrades Downgrades New Coverage Price Target Changes Rating Reiterations Canadian Analyst Ratings (TSE and TSV) U.K. Analyst Ratings (LSE) Australian Analyst Ratings (ASX) Lookup Company Ratings Free Ratings Newsletter ARN Daily Premium ($) RatingsDB ($) Stock Ratings App Earnings Today's Announcements Tomorrow's Announcements Free Earnings Newsletter CER Wire Premium ($) Lookup Company Earnings Dividends Insider Trades About Contact Allscripts Healthcare Solutions Company Profile (NASDAQ:MDRX) Tweet Analyst RatingsEarningsDividendsInsider TradesCompany ProfileSocial ActivityToday's Chart Consensus Ratings for Allscripts Healthcare Solutions (NASDAQ:MDRX) (?) The ratings breakdown includes the most recent rating from each analyst that has rated the stock within the last twelve months. The ratings score is a calculation of the average number of sell, hold, buy and strong buy ratings (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). The consensus price target is a mean average of the most recent price target set by each analyst that has set a price target for the stock in the last twelve months.Ratings Breakdown: 11 Hold Rating(s), 6 Buy Rating(s)Consensus Rating:Hold (Score: 2.35)Consensus Price Target: $18.43 0.24% downside) Analysts' Ratings History for Allscripts Healthcare Solutions (NASDAQ:MDRX) Show: All Ratings For This Stock Only the Most Recent Rating From Each Brokerage DateFirmActionRatingPrice TargetDetailsShare3/5/2014BarclaysInitiated CoverageEqual Weight$20.00View 2/25/2014UBS AGReiterated RatingNeutral$14.50 -> $19.00View 2/24/2014ZacksReiterated RatingNeutral -> Neutral$19.00View 2/21/2014Morgan StanleyReiterated RatingOverweight$20.00 -> $21.00View 2/21/2014FBR Capital MarketsBoost Price TargetMarket Perform$16.00 -> $18.00View 2/21/2014Robert W. BairdBoost Price Target$20.00 -> $23.00View 2/21/2014Leerink SwannBoost Price Target$18.00 -> $23.00View 2/18/2014Citigroup Inc.Initiated CoverageBuy -> NeutralView 2/13/2014RBC CapitalInitiated CoverageNeutral -> Outperform$20.00View 2/11/2014Maxim GroupUpgradeHold -> Buy$20.00View 1/24/2014Robert W. BairdBoost Price Target$18.00 -> $20.00View 1/21/2014B. RileyUpgradeSell -> Neutral$13.00 -> $16.00View 1/15/2014Morgan StanleyReiterated RatingOverweight$17.00 -> $20.00View 1/6/2014B. RileyDowngradeNeutral -> SellView 12/9/2013JPMorgan Chase & Co.Initiated CoverageOverweight$18.00View 11/20/2013Deutsche BankInitiated CoverageBuy$19.00View 11/15/2013Leerink SwannUpgradeMarket Perform -> Outperform$16.00 -> $18.00View 11/8/2013Robert W. BairdBoost Price Target$17.00 -> $18.00View 11/8/2013Cowen and CompanyBoost Price Target$18.00 -> $20.00View 11/8/2013ZacksReiterated RatingNeutral -> Neutral$15.00View 10/31/2013FBR Capital MarketsInitiated CoverageMarket Perform$16.00View 10/29/2013Robert W. BairdLower Price TargetOutperform$18.00 -> $17.00View 10/17/2013StephensInitiated CoverageEqual WeightView 9/19/2013ZacksReiterated RatingNeutral -> Neutral$15.00View 9/4/2013KeyCorpInitiated CoverageHoldView 8/13/2013Raymond JamesBoost Price Target$16.00 -> $17.00View 8/9/2013Robert W. BairdBoost Price Target$16.00 -> $18.00View 7/15/2013Lazard Capital MarketsBoost Price Target$12.00 -> $14.00View 7/15/2013Credit SuisseBoost Price Target$16.00 -> $18.00View 7/15/2013ISI GroupDowngradeBuy -> Neutral$15.50 -> $16.50View 6/19/2013Goldman SachsReiterated RatingHold$15.00View 6/19/2013ISI GroupBoost Price TargetBuy$14.50 -> $15.50View 6/11/2013Sterne AgeeInitiated CoverageBuy$17.00View 6/4/2013Goldman SachsInitiated CoverageNeutral$15.00View 5/31/2013Jefferies GroupBoost Price TargetHold$13.00 -> $15.00View 5/23/2013Raymond JamesDowngradeStrong-Buy -> OutperformView 5/14/2013Citigroup Inc.UpgradeNeutral -> Buy$18.00View 5/13/2013Jefferies GroupBoost Price TargetHold$11.50 -> $13.00View 5/13/2013Credit SuisseBoost Price TargetNeutral$15.00 -> $16.00View 4/26/2013Morgan StanleyUpgradeEqual Weight -> Overweight$16.00View 4/18/2013Robert W. BairdReiterated RatingBuy$16.00View 4/18/2013Maxim GroupDowngradeBuy -> HoldView 3/28/2013B. RileyInitiated CoverageNeutralView 3/15/2013Robert W. BairdBoost Price TargetOutperform$13.00 -> $16.00View 2/27/2013Credit SuisseUpgradeNeutral -> Outperform$13.00 -> $15.00View 2/20/2013Jefferies GroupBoost Price Target$10.00 -> $11.50View 2/20/2013ISI GroupReiterated RatingBuy$10.50 -> $14.00View 1/14/2013Raymond JamesUpgradeMarket Perform -> Strong-Buy$13.00View 1/7/2013Avondale PartnersUpgradeMarket Perform -> OutperformView 12/21/2012Jefferies GroupLower Price TargetHold$13.00 -> $10.00View 12/21/2012ArgusDowngradeBuy -> HoldView 12/21/2012Robert W. BairdLower Price TargetOutperform$16.00 -> $11.00View 12/20/2012Leerink SwannReiterated RatingMarket PerformView 11/30/2012Sterne AgeeReiterated RatingBuyView 11/27/2012JMP SecuritiesInitiated CoverageMarket PerformView 11/9/2012Jefferies GroupBoost Price TargetHold$10.50 -> $13.00View 11/9/2012Piper JaffrayDowngradeNeutral -> Underweight$12.00 -> $7.00View 10/4/2012Maxim GroupBoost Price TargetBuy$13.00 -> $15.00View 10/1/2012Sterne AgeeBoost Price TargetBuy$13.50 -> $15.00View 10/1/2012Robert W. BairdBoost Price TargetOutperform$15.00 -> $17.00View 10/1/2012Cowen and CompanyUpgradeNeutral -> OutperformView 10/1/2012ISI GroupUpgradeHold -> Overweight$11.50 -> $14.50View 8/9/2012JPMorgan Chase & Co.Boost Price TargetNeutral -> Overweight$12.00 -> $15.00View 7/18/2012Citigroup Inc.Boost Price TargetNeutral$10.50 -> $11.00View 7/11/2012ISI GroupInitiated CoverageMarket Weight$11.00View 6/18/2012Leerink SwannReiterated RatingMarket PerformView 5/29/2012Wells Fargo & Co.Initiated CoverageMarket PerformView 5/23/2012Lazard Ltd.Initiated CoverageNeutralView 4/30/2012Raymond JamesDowngradeOutperform -> Market PerformView 4/29/2012Goldman SachsLower Price TargetNeutral$21.00 -> $13.00View 4/27/2012William BlairDowngradeMarket PerformView 4/27/2012Avondale PartnersDowngradeMarket Perform -> UnderperformView 4/27/2012BarclaysDowngradeOverweight -> Equal WeightView 4/27/2012Citigroup Inc.DowngradeBuy -> Neutral$24.00 -> $10.50View 4/27/2012Caris & Co.DowngradeBuy -> AverageView 4/27/2012Cowen and CompanyDowngradeOutperform -> NeutralView 4/27/2012OppenheimerDowngradeOutperform -> Market PerformView 4/27/2012Piper JaffrayDowngradeOverweight -> Neutral$24.00 -> $11.00View 4/27/2012Jefferies GroupDowngradeBuy -> Hold$10.50View 4/27/2012UBS AGDowngradeBuy -> Neutral$26.00 -> $10.00View 4/27/2012Credit SuisseDowngradeOutperform -> Neutral$8.00View 3/29/2012AurigaDowngradeBuy -> Hold$19.00View 3/21/2012JPMorgan Chase & Co.DowngradeOverweight -> NeutralView 3/12/2012Credit SuisseInitiated CoverageOutperform$23.00View (Data available from 3/8/2012 forward) Earnings History for Allscripts Healthcare Solutions (NASDAQ:MDRX)DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetailsShare2/20/2014Q413$0.08$0.08$343.47 million$351.00 millionViewListenView 11/7/2013Q313$0.08$0.05$355.30 million$334.00 millionViewListenView 8/8/2013Q2 2013$0.11$0.09$360.00 million$344.80 millionViewListenView 5/9/2013Q1 2013$0.14$0.09$368.11 million$347.10 millionViewListenView 2/19/2013Q4 2012$0.21$0.16$367.07 million$367.70 millionViewListenView 11/8/2012Q312$0.22$0.23$376.97 million$361.00 millionViewN/AView 8/8/2012$0.18$0.16ViewN/AView 4/26/2012$0.24$0.12ViewN/AView 2/16/2012$0.25$0.25ViewN/AView 11/3/2011$0.22$0.25ViewN/AView 8/2/2011$0.21$0.22ViewN/AView 5/5/2011$0.20$0.21ViewN/AView 2/15/2011$0.18$0.20ViewN/AView (Data available from 1/1/2011 forward) Dividend History for Allscripts Healthcare Solutions (NASDAQ:MDRX)No dividend announcements for this company have been tracked by Analyst Ratings Network Insider Trading History for Allscripts Healthcare Solutions (NASDAQ:MDRX)Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionSEC LinkShare11/21/2013Deborah SnowSVPSell2,400$14.70$35,280.00View 9/9/2013Clifford B MeltzerEVPSell35,000$14.56$509,600.00View 8/15/2013Michael KlaykoDirectorBuy10,000$14.80$148,000.00View 5/30/2013Deborah SnowSVPSell1,495$13.71$20,496.45View 5/20/2013Stuart L BascombDirectorBuy3,701$14.02$51,888.02View 5/15/2013Paul BlackCEOBuy7,120$14.02$99,822.40View 5/14/2013Steve ShuteVPSell14,612$14.10$206,029.20View 3/12/2013Paul BlackCEOBuy23,625$12.69$299,801.25View 3/12/2013Stuart L BascombDirectorBuy10,000$12.64$126,400.00View (Data available from 1/1/2013 forward) About Allscripts Healthcare Solutions Allscripts Healthcare Solutions, Inc. (Allscripts) is a provider of clinical, financial, connectivity and information solutions and related professional services to hospitals, physicians and post-acute organizations. The Company provides a variety of integrated clinical software applications for hospitals, physician practices and post-acute organizations. For hospitals and health systems these applications include its Sunrise Enterprise suite of clinical solutions, consisting of a range of acute care Electronic Health Record (EHR), integrated with financial/administrative solutions, including performance management and revenue cycle/access management. The Company's acute care solutions include Emergency Department Information System (EDIS), care management and discharge management. On February 24, 2011, Misys plc (Misys) disposed of its remaining interest in Allscripts. Effective March 5, 2013, Allscripts Healthcare Solutions Inc acquired Jardogs LLC. and dbMotion Ltd. Headlines: (2/21) Allscripts Healthcare Solutions Earnings Continue to Fall (2/24) Allscripts Healthcare Solutions, Inc. (MDRX): New Analyst Report from Zacks Equity Research - Zacks Equity Research ... (2/20) Allscripts announces fourth quarter and 2013 results (2/18) Press Release (2/24) Allscripts Healthcare Solutions Larger Than S&P 500 Component Cliffs Natural Resources (2/20) Earnings Reaction History: Allscripts Healthcare Solutions, Inc., 50.0% Follow-Through Indicator, 6.0% Sensitive (2/10) Black Book Names Allscripts Top HIE Vendor in User Satisfaction Survey (2/20) Allscripts Healthcare Reports Q4 Adj. Profit In Line Industry, Sector and Symbol: Sector: Healthcare Industry: Health Care Technology Sub-Industry: Health Care Technology Exchange: NASDAQ Symbol: MDRX CUSIP: 01988P10 Key Metrics: Previous Close: $18.4050 Day Moving Average: $17.2226200 Day Moving Average: $15.44 P/E Ratio: N/AP/E Growth: 2.11Market Cap: $3.297BCurrent Quarter EPS Consensus Estimate: $0.42 EPS Additional Links: View MDRX on Google FinanceView MDRX on Yahoo FinanceView MDRX's Company Profile on ReutersSearch for Allscripts Healthcare Solutions Inc on Google Allscripts Healthcare Solutions (NASDAQ:MDRX) Chart for Saturday, March, 8, 2014 (Chart Provided by Yahoo Finance) © Analyst Ratings Network 2010-2014. All rights reserved. Contact | Terms and Conditions | Subscribe | Subscribe Earnings | Google+ Analyst Ratings Network does not provide financial advice and does not issue recommendations or offers to buy or sell any security. Learn more.